COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare)
Abstract
Background: People with intellectual disabilities (ID) were identified as one of the vulnerable groups during the COVID-19 pandemic. However, few studies have investigated a comprehensive set of COVID-19-related outcomes. The aim of this study is therefore to describe COVID-19-related diagnoses, hospitalizations, deaths, and vaccinations among people with ID compared to the general population.
Methods: This register-based cohort study included all people living in Skåne, Sweden, on January 1st, 2014. People with ID and still alive January 1st, 2020, constituted the ID cohort ( n = 14 046). Those remaining after excluding people in the same family/household comprised the general population cohort (gPop, n = 1 157 138). Data regarding outcomes were collected from Swedish national and regional registers for 2020 and 2021.
Results: People in the ID cohort had higher risk of being diagnosed with COVID-19 but were less likely than those in the gPop cohort to have the diagnosis confirmed by laboratory test. Adults and older people in the ID cohort had higher COVID-19 related healthcare utilization in terms of physical primary care visits in 2020 and hospitalizations in both 2020 and 2021, with some sex and age differences within the ID cohort. Among those with at least one physical primary care contact, adults and older women in the ID cohort had fewer contacts in 2020 compared to their peers in the gPop cohort. Where the number of observations allowed for analyses, people in the ID cohort had higher risk of death from COVID-19 than those in the gPop cohort.
Conclusions: People with ID had similar healthcare utilization as the general population during the COVID-19 pandemic, with the same or higher levels of COVID-related healthcare, and similar vaccination rates. However, people with ID with healthcare contacts had fewer contacts and bed days and higher mortality. Overall, the Swedish COVID-19 strategy regarding vaccination and healthcare prioritization for people with ID seems to have worked as intended.
Related
- Exome-wide rare variant genetic load is associated with cognition, intellectual disability and psychiatric disorders in population-based cohorts
- How often do Australian government-funded interventional trials exclude adults with intellectual disability? A retrospective registry analysis of ANZCTR records, 2022-2024.
- An adaptive technical and behavioral approach for biomarker acquisition in autism with intellectual disability
- Nutraceutical, Nutritional and Phytotherapeutic Interventions for Neuropsychiatric Disorders Associated with Intellectual Disability: Mechanisms and Clinical Evidence
- Primary aldosteronism with intellectual disability associated with CACNA1H and PPP2R5D mutations: a case report with review of literature
BibTeX
@article{sandberg2026covid19,
title = {{COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare)}},
author = {Magnus Sandberg and Jimmie Kristensson and Anna Axmon},
journal = {BMC Public Health},
year = {2026},
month = oct,
doi = {10.1186/s12889-026-29868-8},
url = {https://link.springer.com/article/10.1186/s12889-026-29868-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare)
AU - Magnus Sandberg
AU - Jimmie Kristensson
AU - Anna Axmon
PY - 2026
DA - 2026/10/15
JO - BMC Public Health
DO - 10.1186/s12889-026-29868-8
UR - https://link.springer.com/article/10.1186/s12889-026-29868-8
AB - Background: People with intellectual disabilities (ID) were identified as one of the vulnerable groups during the COVID-19 pandemic. However, few studies have investigated a comprehensive set of COVID-19-related outcomes. The aim of this study is therefore to describe COVID-19-related diagnoses, hospitalizations, deaths, and vaccinations among people with ID compared to the general population. Methods: This register-based cohort study included all people living in Skåne, Sweden, on January 1st, 2014. People with ID and still alive January 1st, 2020, constituted the ID cohort ( n = 14 046). Those remaining after excluding people in the same family/household comprised the general population cohort (gPop, n = 1 157 138). Data regarding outcomes were collected from Swedish national and regional registers for 2020 and 2021. Results: People in the ID cohort had higher risk of being diagnosed with COVID-19 but were less likely than those in the gPop cohort to have the diagnosis confirmed by laboratory test. Adults and older people in the ID cohort had higher COVID-19 related healthcare utilization in terms of physical primary care visits in 2020 and hospitalizations in both 2020 and 2021, with some sex and age differences within the ID cohort. Among those with at least one physical primary care contact, adults and older women in the ID cohort had fewer contacts in 2020 compared to their peers in the gPop cohort. Where the number of observations allowed for analyses, people in the ID cohort had higher risk of death from COVID-19 than those in the gPop cohort. Conclusions: People with ID had similar healthcare utilization as the general population during the COVID-19 pandemic, with the same or higher levels of COVID-related healthcare, and similar vaccination rates. However, people with ID with healthcare contacts had fewer contacts and bed days and higher mortality. Overall, the Swedish COVID-19 strategy regarding vaccination and healthcare prioritization for people with ID seems to have worked as intended.
SN - 1471-2458
ER -